˘
H. C¸ avdar, N. Sarac¸oglu / Tetrahedron 61 (2005) 2401–2405
2404
compound 6. The crystallization of the residue from CHCl3/
hexane gave dark yellow powder; mp 145–146 8C: 1H NMR
(200 MHz, CDCl3): d 8.38 (m, NH, 1H), 5.88–5.82 (m,
]CH, pyrrole and cyclohexadiene ring, 3H), 4.39 (dd, JZ
9.4, 7.7 Hz, CH, 1H), 3.43 (dd, JZ18.7, 9.4 Hz, A part of
AB system, CH2, 1H), 3.33–3.15 (m, CH2, 5H); 13C NMR
(50 MHz, CDCl3): d 173.51, 170.95, 128.11, 127.55,
124.56, 123.23, 116.57, 107.16, 41.78, 36.29, 26.65,
25.81; IR (CH2Cl2, cmK1): 3401, 3031, 2861, 2831, 1859,
1774, 1604, 1411, 1272, 1234, 1149, 1072, 1002. Anal.
calcd for C12H11NO3: C, 66.35; H, 5.10; N, 6.45. Found: C,
67.03; H, 5.04; N, 6.39.
A solution of 4,7-dihydroindole (3) (300 mg, 2.52 mmol),
1,3-diphenyl-propenone (10) (132 mg, 0.63 mmol) and
Bi(NO3)3 (219 mg, 0.45 mmol) in 2 mL CH2Cl2 was stirred
at room temperature for 16 h. After the solvent was
evaporated, the residue was filtered on a short silica gel
column (5 g) eluting with CH2Cl2 (100 mL). The crude
product (432 mg, 1.32 mmol) and 147 mg (1.32 mmol)
p-benzoquinone were dissolved in CH2Cl2 (20 mL) and
stirred at room temperature for 24 h. Reaction mixture was
diluted with CH2Cl2 (100 mL), and the organic phase was
washed with NaOH (2!50 mL, 10%), washed with water
(2!50 mL) and dried over MgSO4. After removal of the
solvent, the residue was purified on a silica gel column
(50 g) eluting with ethyl acetate/hexane (5%) to give 40 mg
of unreacted 1,3-diphenyl-propenone (10) as the first
fraction. Further elution with ethyl acetate/hexane (5%)
furnished the product 15: (242 mg, 30%) yellow crystals
from CH2Cl2/hexane; mp 124–125 8C; 1H NMR (200 MHz,
CDCl3): d 8.23 (m, NH, 1H), 8.02–7.97 (m, 2H), 7.63–7.50
(m, 4H), 7.48–7.23 (m, 6H), 7.15–7.00 (m, 2H), 6.20 (m,
]CH, H3, 1H), 4.96 (dd, JZ7.7 Hz, 5.5 Hz, CH, 1H), 3.92
(dd, JZ17.7, 7.7 Hz, A part of AB system, CH2, 1H), 3.70
(dd, JZ17.7, 5.5 Hz, B part of AB system, CH2, 1H); 13C
NMR (50 MHz, CDCl3): d 200.56, 144.26, 143.66, 138.80,
138.14, 135.41, 130.81, 130.69, 130.17, 130.12, 129.13,
123.51, 122.07, 121.63, 114.63, 112,62, 101.96, 46.92,
41.76; IR (CH2Cl2, cmK1): 3392, 3046, 2923, 2869, 1684,
1600, 1458, 1346, 1292, 1253, 1223, 992, 753, 700. Anal.
calcd for C23H19NO: C, 84.89; H, 5.89; N, 4.30. Found: C,
85.01; H, 5.74; N, 4.41.
3.1.3. 3-(1H-Indol-2-yl)-furan-2,5-dione (8). To a stirred
solution of 6 (152 mg, 0.71 mmol) in 10 mL of dry benzene
(CAUTION-CARCINOGENIC) was added a solution of
DDQ (355 mg, 1.54 mmol). After the addition was
complete, stirring was continued for 1 h at room tempera-
ture. The solvent was evaporated and residue was filtered on
a short silica gel column (5 g) eluting with CH2Cl2
(100 mL). The residue (148 mg, 99%) was recrystallized
from ethyl acetate/hexane to give 8 as dark brown powder
(135 mg, 90%); mp 223–224 8C: 1H NMR (200 MHz,
CD3COCD3): d 11.00 (m, NH, 1H), 7.71 (d, JZ7.7 Hz, A
part of AB system, 1H), 7.55 (d, JZ1.5 Hz, H-3, 1H), 7.48
(d, JZ7.7 Hz, A part of AB system, 1H), 7.31 (bt, JZ
7.7 Hz, A part of AB system, 1H), 7.12 (s, 1H), 7.11 (d, JZ
7.7 Hz, B part of AB system, 1H); 13C NMR (50 MHz,
CD3COCD3): d 167.61, 167.25, 142.13, 141.26, 131.02,
129.94, 128.94, 125.20, 123.74, 123.45, 121.40, 116.35,
114.76, 114.06; IR (CH2Cl2, cmK1): 3394, 1835, 1766,
1619, 1511, 1411, 1280, 1241, 1141, 910. Anal. calcd for
C12H7NO3: C, 67.61; H, 3.31; N, 6.57. Found: C, 67.04; H,
3.26; N, 6.69.
3.1.6. 3-(1H-Indol-2-yl)-cyclohexanone (16). A solution of
4,7-dihydroindole (3) (100 mg, 0.84 mmol), 2-cyclo-
hexenone (11) (81 mg, 0.84 mmol) and Bi(NO3)3 (73 mg,
0.30 mmol) in 2 mL CH2Cl2 was stirred at room tempera-
ture for 16 h. After the solvent was evaporated, the residue
was filtered on a short silica gel column (5 g) eluting with
CH2Cl2 (100 mL). The crude product (181 mg, 0.82 mmol)
and p-benzoquinone (98 mg, 0.90 mmol) were dissolved in
CH2Cl2 (20 mL) and stirred at room temperature for 24 h.
Reaction mixture was diluted with CH2Cl2 (100 mL), and
the organic phase was washed with NaOH (2!50 mL,
10%), washed with water (2!50 mL) and dried over
MgSO4. After removal of the solvent, the residue was
filtered on a silica gel column (45 g) eluting with ethyl
acetate/hexane (20%) to give 90 mg (49%) as a dark brown
powder which was recrystallized from CH2Cl2/hexane; mp
3.1.4. Reaction of 4,7-dihydroindole (3) diethyl azo-
dicarboxylate (9). A solution of 4,7-dihydroindole (3)
(179 mg, 1.50 mmol), diethyl azodicarboxylate (9)
(502 mg, 3.01 mmol) and Bi(NO3)3 (117 mg, 0.24 mmol)
in 2 mL CH2Cl2 was stirred at room temperature for 16 h.
The residue was filtered on a silica gel column (60 g) eluting
with ethyl acetate/hexane (5%) to give the indole derivative
13, which was crystallized from CH2Cl2/hexane (140 mg,
45%, dark grey powders, mp: 115–116 8C. Further elution
with ethyl acetate/hexane (40%) furnished the product 14:
(140 mg, 40%) colourless powder from CH2Cl2/hexane; mp
119–120 8C (lit.12 mp 128–130 8C); For 13: 1H NMR
(200 MHz, CDCl3): d 9.76 (m, NH, 1H), 7.51 (bd, JZ
6.6 Hz, 1H), 7.31 (bd, JZ7.7 Hz, 1H), 7.26–7.06 (m, 2H),
6.12 (m, ]CH, H-3, 1H), 4.37–4.15 (m, CH2, 4H), 1.36–
1.17 (m, CH3, 6H); 13C NMR (50 MHz, CDCl3): d 157.75,
156.08, 135.26, 129.07, 123.36, 123.22, 122.11, 121.91,
121.83, 112.86, 65.64, 64.70, 16.38 (2C); IR (CH2Cl2,
cmK1): 3324, 3062, 2993, 2931, 1720, 1627, 1604, 1558,
1465, 1380, 1319, 1249, 1172, 1072, 1010. Anal. calcd for
C14H17N3O4: C, 57.72; H, 5.88; N, 14.42. Found: C, 57.56;
1
148–149 8C; H NMR (200 MHz, CDCl3): d 8.10 (m, NH,
1H), 7.56 (bd, JZ6.5 Hz, 1H), 7.32 (bd, JZ8.0 Hz, 1H),
7.20–7.05 (m, 2H), 6.28 (bs, ]CH, H3, 1H), 3.26 (pentet,
JZ4.8 Hz, CH, 1H), 2.85–1.75 (m, CH2, 8H); 13C NMR
(50 MHz, CDCl3): d 212.26, 143.32, 137.84, 130.35,
123.66, 122.19, 121.90, 112.57, 100.86, 49.06, 43.28,
39.73, 33.23, 26.67; IR (CH2Cl2, cmK1): 3340, 3054,
2939, 2861, 1704, 1643, 1596, 1550, 1457, 1419, 1349,
1311, 1234, 1172, 1141. Anal. calcd for C14H15NO: C,
78.84; H, 7.09; N, 6.57. Found: C, 79.01; H, 6.97; N, 6.71.
1
H, 5.97; N, 14.30. For 14: H NMR (200 MHz, CDCl3): d
6.62 (m, NH, 2H), 4.20 (q, JZ7.1 Hz, OCH2, 4H), 1.27 (t,
JZ7.1 Hz, CH3, 6H); 13C NMR (50 MHz, CDCl3): d
158.73, 64.25, 16.39; IR (CH2Cl2, cmK1): 3301, 2993,
1712, 1519, 1380, 1326, 1241, 1072.
3.1.7. 3-(1H-Indol-2-yl)-cyclopentanone (17). A solution
of 4,7-dihydroindole (3) (200 mg, 1.68 mmol), 2-cyclo-
pentenone (12) (146 mg, 1.68 mmol) and Bi(NO3)3
(146 mg, 0.37 mmol) in 2 mL CH2Cl2 was stirred at room
temperature for 16 h. After the solvent was evaporated, the
3.1.5. 3-(1H-Indol-2-yl)-1,3-diphenyl-propan-1-one (15).